Press "Enter" to skip to content

Global Neurodegenerative Disease Market 2021 Production, Revenue, Price and Gross Margin Analysis with Forecasts

Neurodegenerative Disease

The report focuses on the favorable Global “Neurodegenerative Disease market” and its expanding nature. The Neurodegenerative Disease market report provides a comprehensive study of the market segmentation, service providers, stockholders, sponsors, and important market players, size, and share, market dynamics such as the growth drivers, restraints, challenges, and opportunities.

Market Overview:

  • The major factors for the growth of the neurodegenerative disease market include the rising prevalence of neurological disorders, increasing public awareness, and strong product pipeline for neurodegenerative disease treatment.
  • With increasing global population and average lifespan, the prevalence of neurological disorders is on the rise, worldwide. According to a study by the Parkinson’s Disease Foundation, the number of new cases of the disease has increased over the last 30 years. Globally, over 10 million people are living with Parkinson’s disease, according to the statistics of 2016. The Alzheimer’s Association stated that around 5.4 million people in the were living with Alzheimer’s disease, in 2016. This disease is the sixth-leading cause of death in the United States, and is more prevalent among people above 65 years of age, as 5.2 million out of the 5.4 million patients fall in this age bracket. The increase in global average age contributes to increased prevalence of Amyotrophic Lateral Sclerosis (ALS), since the disease is most prevalent in people above 60 years of age. According to a report, approximately 4 out of 10,000 people in the had ALS in 2015, which is expected to increase in the coming years. At present, around 30,000 people in the are estimated to be suffering from Huntington’s disease. The prevalence of these diseases among all races, genders, and geographical backgrounds is increasing with the rise in the world population. The aforementioned numbers suggest that the prevalence of neurodegenerative disorders is on the rise, contributing to the growth of the market over the forecast period.

    Request a sample copy of the report –

    Key Manufacturers

  • AbbVie Inc.
  • Amneal Pharmaceuticals Inc.
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann
  • La Roche Ltd
  • GlaxoSmithKline PLC
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical
  • UCB SA

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    Neurodegenerative Disease market report focuses on the latest trends in the global and regional spaces on all the significant components, including the capacity, cost, price, technology, supplies, production, profit, and competition. Moreover, the old data and present development of the Neurodegenerative Disease market have been given in the scope of the report. The latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Neurodegenerative Disease market have also been involved in the study.

    Scope of the Report:

  • As per the scope of this report, neurodegenerative disease is a broad term used to denote a range of conditions that primarily affect the neurons in the brain. Neurodegenerative diseases are incurable, and the degradation of neurons leads to the gradual death of neurons. The market is segmented by indication type, drug type, and geography.

    Inquire Or Share Your Questions If Any Before The Purchasing This Report –

    TOC of Neurodegenerative Disease Market Report Covered:

    Introduction, Research Methodology, Executive Summary, Key Inferences, Market Overview, Neurodegenerative Disease market Dynamics, Market Segmentation, Competitive Landscape, Key Players, Future of the Market, and continued…

    Reasons to Purchase Neurodegenerative Disease Market Report Covered:

    • The report analyses how Neurodegenerative Disease market will grow in the future.
    • Analyzing various perspectives of the Neurodegenerative Disease market with the help of Porter’s five forces analysis.
    • Study on the product type that is expected to dominate the market and regions that are expected to witness the fastest growth during the forecast period
    • Recognize the new developments, Neurodegenerative Disease market shares and policies employed by the major market players.
    • Competitive landscape including the Neurodegenerative Disease market share of major players along with the key policies accepted for development in the past five years
    • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis and strategies employed by the major Neurodegenerative Disease market players

    Key Market Trends:

    Parkinson’s Disease Segment by Indication Type is Expected to Be the Fastest Growing Segment

    The initial symptoms of Parkinson’s disease include shaking, rigidity, uneasiness in walking, and slowness. Anxiety and depression are very common in patients suffering from Parkinson’s disease. Anti-Parkinson drugs, such as Levodopa and Carbidopa, are the most commonly administered drugs, along with dopamine agonists. Ropinirole, Pramipexole, and Rotigotine are some common dopamine agonists prescribed for the disease. Selegiline and Rasagiline are the drugs that conserve dopamine and prevent degradation. COMT inhibitors are also administered to prevent the degradation of dopamine. According to the Parkinson’s Disease Foundation, nearly 10 million people worldwide are living with Parkinson’s disease. The risk of Parkinson’s disease increases with age. The growing aging population, especially in North America and , is the primary factor propelling the growth of the market. The increasing awareness and incidences of the disease are boosting the market growth. According to the Parkinson’s Disease Foundation, medication cost for a patient with the disease is on an average USD 2,500 a year, and therapeutic surgery costs nearly USD 100,000 per person. In 2017, North America accounted for the largest market, followed by and Asia-Pacific.

    North America is Expected to Dominate the Market

    North America is the most significant region in Parkinson’s drugs market. As many as one million Americans live with Parkinson’s disease (PD), which is more than the combined number of people diagnosed with multiple sclerosis, muscular dystrophy, and Lou Gehrig’s disease. According to Parkinson’s news, 2018, approximately 1.2 million people in the are predicted to have Parkinson’s disease by 2030. It is the second-most common neurodegenerative disorder in the United States. Also, there are thousands of patients who go undetected. As the US population continues to age, the number of people living with Parkinson disease (PD) continues to grow, and it is expected to double between 2010 and 2040. Recently, the Food and Drug Administration (FDA) approved safinamide (Xadago) tablets as an add-on treatment to levodopa/carbidopa for patients with PD, who are experiencing “off” episodes. FDA approved the drug in March 2017. On the other hand, patients are adopting the generics due to the low cost, and are further expected to restrain the patented drugs. Hence, this generic competition between the new entrants is expected to show a steady growth rate, during the forecast period.

    Purchase This Report (Price 4250 USD for single user license) –   

    Study objectives of Neurodegenerative Disease Market Report:

    • To provide a detailed analysis of the market structure along with the Neurodegenerative Disease market forecast of various segments and sub-segments of the Neurodegenerative Disease market
    • To provide insights into factors influencing and affecting market growth
    • To provide historical, current, and forecast revenue of market segments based on material, type, design, and end user
    • To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
    • To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
    • To provide economic factors, technology and Neurodegenerative Disease market trends that influence the global Neurodegenerative Disease market

    Detailed TOC of Neurodegenerative Disease Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Prevalence of Neurological Disorders
    4.2.2 Increasing Public Awareness
    4.2.3 Strong Product Pipeline for Neurodegenerative Disease Treatment
    4.3 Market Restraints
    4.3.1 Patent Expiry of Neurodegenerative Disease Treatment Products
    4.3.2 Stringent Regulatory Guidelines
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Indication Type
    5.1.1 Parkinson’s Disease
    5.1.2 Amyotrophic Lateral Sclerosis
    5.1.3 Alzheimer’s Disease
    5.1.4 Huntington Disease
    5.1.5 Other Indication Types
    5.2 By Drug Type
    5.2.1 N-methyl-D-aspartate Receptor
    5.2.2 Selective Serotonin Reuptake Inhibitor
    5.2.3 Dopamine Inhibitors
    5.2.4 Other Drug Types
    5.3 Geography
    5.3.1 North America United States Canada Mexico
    5.3.2 Germany United Kingdom France Italy Spain Rest of
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 AbbVie Inc.
    6.1.2 Amneal Pharmaceuticals Inc.
    6.1.3 Boehringer Ingelheim International GmbH
    6.1.4 F. Hoffmann-La Roche Ltd
    6.1.5 GlaxoSmithKline PLC
    6.1.6 Merck & Co. Inc.
    6.1.7 Pfizer Inc.
    6.1.8 Teva Pharmaceutical
    6.1.9 UCB SA



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other report :
    Global High Voltage Power Amplifiers Market Share 2021 Overview with Definition and Market Characteristics to Enhancement Growth- COVID-19 Impact and Recovery

    Global Thread Sealant Market 2021: Leading Players Updates, Industry Demand, Share, Size, Regional Trend, Future Growth, Current and Future Plans by Forecast to 2026

    Global Blower Purge Regenerative Air Dryers Market 2021: Market Size, Share, Growth, Sales and Drivers Analysis Research Report 2027 with COVID-19 Impact

    Global Micro Pig Feed Market Share 2021 Overview with Definition and Market Characteristics to Enhancement Growth- COVID-19 Impact and Recovery

    Sun Protection Lip Products Market 2021: global Industry Updates, Upcoming Growth, Prominent Players, Forthcoming Development, Business Prospects and Future Investments by Forecast to 2027

    Waste Water Filter Market Size, Share, Supply, Demand, Segments and Forecast 2021-2027 with COVID-19 Impact

    Global Tape Wound Cores Market Analysis and Forecast to 2027 by Recent Trends, Developments in Manufacturing Technology and Regional Growth Overview

    Global Flange Nut Market 2021|Growth Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries

    Van EPS Market Size, Share, Supply, Demand, Segments and Forecast 2021-2027 with COVID-19 Impact

    Waste Processor Market Industry 2021, COVID-19 Impact, Global Market Growth, Size, Demand, Trends, Insights and Forecast 2027

    Global Mobile Phone Charger Market 2021: Analysis of Post COVID-19 Impact, Growth Forecast Analysis by Manufacturers, Regions, Type and Application

    Global Nickel-plated Steel Sheet in Batteries Market 2021 Supply, Consumption, Cost and Profit analysis and forecast to 2027